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Inhibition of nuclear uptake of calcitriol receptor by uremic ultrafil-
trate. The biological action of calcitriol is mediated through a hormone-
receptor complex interacting with nuclear chromatin. Interaction of the
calcitriol receptor (VDR) with VDR response elements produces bio-
active proteins which carry out the physiological actions of calcitriol.
Since biological response to calcitriol appears to be diminished in renal
failure, we studied the effect of uremic toxins on the interaction of VDR
with nuclear chromatin using in vitro nuclear uptake of the 3H-calcitriol
labeled VDR by intestinal nuclei. We found that nuclear uptake of the
labeled intestinal VDR from renal failure rats was significantly lower
than that from the control animals. HPLC fractionated uremic ultrafil-
trate directly inhibited nuclear uptake of the labeled VDR when the
labeled VDR was incubated with 50% of the ultrafiltrate for various time
intervals ranging from 15 minutes to 6 hours. Infusion of uremic
ultrafiltrate to normal rats for 20 hours also produced intestinal VDR
with a lower binding affinity for intestinal nuclei when compared to the
controls infused with normal ultrafiltrate. The latter study suggests that
uremic toxins are responsible for the decreased nuclear uptake of VDR
of rats with renal failure. Although it is difficult to extrapolate these
results directly to the intact cells, our findings suggest that part of the
calcitriol resistance in renal failure could be explained by decreased
entry of receptor into the nucleus.
Calcitriol receptor (VDR) is a nuclear receptor. It regulates
the expression of target genes by interacting with nuclear
chromatin analogous to other steroid hormones [1]. Thus, the
genomic action of calcitriol depends on the cellular uptake of
calcitriol and the translocation of calcitriol occupied VDR to the
cellular nucleus. Interaction of the VDR with its response
elements produces bioactive proteins and promotes the physi-
ological actions of calcitriol [21. The DNA binding domain of
the VDR is composed of two zinc finger structures. The
structure is stabilized with cysteine-zinc bonding [3] which is
sensitive to chemical modification by sulfliydryl blocking agents
such as iodoacetamide and p-chloromercuribenzoate [4]. The
chemical modification of the domain inhibits the binding of the
VDR to the DNA-cellulose. Other chemical substances with
carbonyl groups, such as pyridoxal 5-phosphate, could form
Schiff bases with the c-amino groups of lysine of the DNA
binding domain and inhibit its binding to DNA-cellulose [5, 61.
Thus, the DNA binding domain of the VDR is susceptible to
chemical modification which diminishes its binding affinity for
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nuclear chromatin. We have previously demonstrated that
uremic plasma contains factors that inhibit the interaction of
VDR with DNA-cellulose [7]. Further, we have shown that
uremic toxins are responsible for the abnormal DNA-cellulose
binding characteristics of VDR in chronic renal failure [8]. In
this experiment, we used intestinal nuclei to study in vitro
nuclear uptake of the labeled VDR in renal failure.
Methods
Nuclear uptake of the intestinal calcitriol receptor from rats
with renal failure
Male Sprague-Dawley rats weighing 200 g were fed a regular
Purina rat chow containing 1.0% Ca, 0.8% P, and 4.5 IU per g
vitamin D. Rats underwent subtotal nephrectomies (N = 6)
under ether anesthesia. One kidney was removed through flank
incision and two-thirds of the other kidney was removed three
days later. Control rats (N = 6) had sham nephrectomies.
Intestinal calcitriol receptor concentrations were prepared in
these animals after they were pair-fed for one week. In addition,
blood was drawn for the measurement of creatinine, Ca, P, and
calcitriol.
Preparation of intestinal VDR. Intestinal cellular protein was
prepared as described previously [8]. Rats were decapitated and
the initial 20 cm of small intestine (duodenum and portion of
jejunum) distal to the pylorus were removed and flushed with
ice-cold Ca/Mg-free phosphate (6.6 mM Na2HPO4, 250 IU
Trasylol and 1.5 mrvt KH2PO4)-buffered saline (CMF-PBS). The
mucosa was scraped from the serosa and washed three times
with 20 volumes (wt/vol) CMF-PBS containing 200 IU/ml
Trasylol. After the third washing, the tissue was homogenized
by a PolXtron in 20 vol (wtlvol) of buffer consisting of 300 mM
KC1, 200 g/ml soybean trypsin inhibitor, 10 mri Tris-HCI (pH
7.4), 1 mri EDTA, 10 m sodium molybdate and 5 mM
dithiothreitol (KTEDM). Cytosol was prepared by centrifuga-
tion at 100,000 x g for 45 minutes at 0 to 4°C.
Preparation of intestinal nuclei. Normal rats were sacrificed
and the initial 20 cm of small intestine was removed [91. The
intestine was washed with ice-cold CMF-PBS solution. All the
following procedures were carried out at 2°C. The mucosa was
scraped from serosa and washed three times with CMF-PBS
solution. After thorough washing the intestinal mucosa was
suspended in 10 volumes of buffer solution containing 10 mM
Tris-HC1, pH 7.4, 2 ms EDTA, 0.5 mM EGTA, 0.15 mM
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spermine, 0.5 msi spermidine, 300 mM KC1, and 5 mrvi dithio-
threitol (HPB) [9]. The tissue was homogenized with a Polytron
and centrifuged at 200 x g for 15 minutes to remove large tissue
particles. The supernatant was centrifuged at 1,700 x g for 15
minutes to precipitate the nuclei. The nuclei were washed twice
and resuspended in HPB solution containing 0.32 M sucrose [9].
The content of DNA was estimated by UV spectrophotometry
(Beckman DU 62 Spectrophotometer equipped with Nucleic
Acid Soft-Pac Module).
Nuclear uptake of the labeled VDR, Nuclear uptake of the
labeled VDR was conducted as previously described [9]. Cy-
tosol was incubated with 1 flM 3H-calcitriol for two hours at
2°C. The calcitriol receptor-hormone complex was separated
from free hormone by adsorption of the latter to dextran-coated
charcoal, followed by centrifugation at 1,600 x g. A portion of
the supernatant was counted for radioactivity to determine the
total binding of 3H-calcitriol by cellular protein. Nonspecific
binding was determined in each cellular protein preparation
from the radioactivity that remained in the bound fraction after
incubation in the presence of a 100-fold excess of cold calcitriol.
Specific binding of calcitriol was calculated by subtracting
nonspecific binding from total binding. Cellular protein concen-
tration was determined by the Bradford method [101. The
concentration of specific 3H-calcitriol binding cellular proteins
of the control and renal failure rats was adjusted so that an
equal amount of the labeled VDR of both groups of rats was
added to the intestinal nuclei for incubation. Approximately 0.2
ml (1 mg) of the labeled cytosol was incubated with 0.2 ml of
intestinal nuclei for 15 minutes, 30 minutes, 60 minutes, 90
minutes, 2 hours, 3 hours, 4 hours and 6 hours and shaken
gently at 2°C in a Dubnoff incubator. At the end of each
incubation period, the labeled calcitriol-receptor complex was
extracted from the nuclei as follows: the incubation sample was
centrifuged at 1,700 x g for 15 minutes to precipitate the nuclei.
The nuclei were washed with one ml of HPB solution containing
0.32 M sucrose. The supernatant was removed and one ml of
KTED containing 1% Triton X-lOO was added to the nuclei [9].
The sample was incubated for 15 minutes at 2°C and then
centrifuged for 15 minutes to remove the nuclei. The superna-
tant containing the labeled VDR was quantified for radioactiv-
ity. The nuclear uptake of the labeled VDR was corrected for a
given quantity of the labeled VDR added in the incubation. In
addition, we have also treated the supernatant with dextran-
coated charcoal and measured the radioactivity in the superna-
tant. We found that the supernatant with or without charcoal
treatment had nearly an identical radioactivity, suggesting that
3H-calcitriol did not dissociate from the VDR during the extrac-
tion procedure. We have also determined the intestinal nuclear
uptake of tritiated calcitriol. Intestinal nuclei was incubated
with 1 flM 3H-calcitriol for three hours at 2°C with or without
100-fold excess of cold calcitriol. The nuclear binding of 3H-
calcitriol was less than 10 cpm for total and nonspecific binding.
Thus, nuclear uptake of 3H-calcitriol was negligible.
Effect ofuremic ultrafiltrate on nuclear uptake of the labeled
normal VDR
Normal and uremic ultrafiltrate were fractionated with semi-
preparative high performance liquid chromatography (HPLC)
on a RSi1 C18, 10 ;. column (length 25 cm, inner diameter 10
mm) at a flow rate of 3 mllmin with a linear gradient mobile
phase of formic acid (0.05 mollliter, pH 4.0) and methanol [11].
The solvent gradient started with 100% formic acid and 0 to 60%
methanol in 45 minutes. Individual peaks were detected by
simultaneous registration of UV-absorption (254 nm) and fluo-
rescence emission (excitationlemission 280/340 nm) in series.
After the ultrafiltrate was fractionated into 13 previously char-
acterized fractions [II], the fractions were combined and ly-
ophilized. We studied the effect of this HPLC fractionated
ultrafiltrate on nuclear uptake of the labeled VDR using intes-
tinal nuclei.
Normal intestinal cellular protein was incubated with I tiM
3H-calcitnol for two hours at 2°C. Approximately 1 mg of the
labeled cellular protein in 0.2 ml was incubated with 0.2 ml of
intestinal nuclei containing 50% HPLC fractionated uremic
(N = 7) or normal (N = 7) plasma ultrafiltrate. Percent of
ultrafiltrate was defined as volume of ultrafiltrate/volume of
incubation medium (for example, 50% was calculated by dis-
solving lyophilized HPLC fractionated ultrafiltrate obtained
from 50 ml ultrafiltrate in 100 ml incubation medium). The
mixtures were incubated for 15 minutes, 30 minutes, 60 min-
utes, 90 minutes, 2 hours, 3 hours, 4 hours and 6 hours and
shaken gently at 2°C in a Dubnoff incubator. At the end of
incubation, nuclear uptake of the labeled VDR was extracted
and its radioactivity was quantified by scintillation counter as
described above.
It should be noted that uremic ultrafiltrate did not affect the
maximal VDR binding of 3H-calcitriol. This was confirmed by
the following study. Approximately 0.15 mg of intestinal cy-
tosol was incubated with a saturating concentration (5 nM) of
3H-calcitriot [12] in the presence of 50% normal or uremic
ultrafiltrate for three hours at 4°C. The maximal VDR specific
binding of 3H-calcitriol was similar between VDR incubated
with uremic (3H-calcitriol specific binding 432.2 4.15 fmollmg
protein, N = 4) and normal (431.7 9.58 fmol/mg protein, N =
4, P = NS) ultrafiltrates.
Nuclear uptake of the labeled VDR obtained from rats
infused with normal or uremic ultrafiltrate
We have previously shown that uremic factor(s) is responsi-
ble for the abnormal DNA binding characteristics of the VDR in
renal failure [8]; therefore, in this experiment we studied
nuclear uptake of the labeled VDR from rats infused with
uremic ultrafiltrate. Seven normal rats were infused for 20 hours
intravenously through femoral vein catheter with 30 ml of
normal plasma ultrafiltrate. Another seven normal rats were
infused for 20 hours with 30 ml of uremic plasma ultraffitrate [8].
Uremic ultrafiltrates were collected at the initiation of dialysis.
Normal plasma ultrafiltrates were obtained by filtering pooled
heparinized plasma through an identical dialyzer used for
collecting uremic ultrafiltrates. The ultrafiltrate electrolytes
were adjusted to the following concentrations: Na 131 mEq/
liter, K 2.7 mEq/liter, Ca 4.6 mg/dl, Mg 1.66 mg/dl, P 4.35
mg/dl, urea nitrogen 18 mg/dl, and creatinine 0.93 mg/dl for the
normal plasma ultrafiltrate, and Na 131 mEq/liter, K 2.7 mEq/
liter, Ca 4.4 mg/dl, Mg 1.66 mgldl, P 4.55 mg/dl, urea nitrogen
113 mg/dl, and creatinine 10.4 mg/dl for the uremic ultrafiltrate.
At the end of ultraliltrate infusion, animals were killed and
intestinal VDRs were prepared as above. Blood was drawn for
the measurement of creatinine, Ca, P, and calcitriol.
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Table 1. Plasma concentrations of creatinine, calcium, phosphorus, and calcitriol in rats with subtotal nephrectomies and sham operations
.
Body weight
g
PC Pc Pp P101
pg/mimg/d!
Controls 258 6.9 0.58 0.02 9.77 0.17 6.75 0.15 84.2 2.6
(N = 6)
Nephrectomy 248 5.77 1.25 0.04 9.90 0.09 6.49 0.23 52.4 3.5(N = 6)
P value NS <0.001 NS NS <0.001
Abbreviations are: Cr, plasma creatinine; RCa, plasma calcium; plasma phosphorus; P thol' plasma calcitriol.
Fig. 1. Intestinal nuclear uptake of the 3H-calcitriol receptor complex
of chronic renal failure and control rats. Nuclear uptake of labeled
VDR was significantly lower in rats with renal failure (S) compared to
control rats (0) (P < 0.001, by repeated measures analysis of variance).
Fig. 2. Effect of 50% HPLC fractionated norma! and uremic u!trafil-
trate on nuclear uptake of the 3H-calcitriol receptor. Nuclear uptake of
the VDR incubated with uremic ultrafiltrate (•) was significantly lower
than the VDR incubated with normal ultrafiltrate (0) (P < 0.001, by
repeated measures analysis of variance).
14000
12000
10000
8000
6000
4000
2000
>
11)
.
CU
CU
U)0
z
>
V
a)
a'ç
CU
a)0
z0
12000
10000
8000
6000
4000
2000
00 1 2 3 4 5 6
Time, hours
0 1 2 3 4 5 6
Time, hours
Nuclear uptake of the labeled VDR was studied by incubating
approximately 0.2 ml of the intestinal nuclei and 0.2 ml of the
labeled VDR of normal or uremic ultrafiltrate infused rats. The
specific 3H-calcitriol binding cellular proteins of both groups of
animals were adjusted to nearly an identical concentration. The
mixture was incubated for four hours at 2°C and one hour at
37°C. Previous study indicated that nuclear uptake of the
labeled VDR is nearly completed after one hour of incubation at
37°C [13]. Nuclear uptake of the labeled VDR was measured as
above.
Other analytical methods
Calcium concentration was measured by atomic absorption
spectrophotometry (model 306; Perkin Elmer, Norwalk, Con-
necticut, USA). The concentration of creatinine and phospho-
rus was measured as described previously [14]. Plasma cal-
citriol was measured in duplicate using a radioreceptor assay
[15]. The intra-assay coefficients of variation were 5.4% for low
control (20 pglml, N = 6) and 4.7% for high control (100 pglml,
N = 6). The inter-assay coefficients of variation were 7% for
low (N 12) and 4.1% for high control (N 12).
All data were expressed as mean SEM. Statistical analysis
was performed using ANOVA with repeated measures and
Student's t-test where appropriate. A P value of less than 0.05
was considered significant.
Results
Nuclear uptake of the intestinal calcitriol receptor from rats
with renal failure
As shown in Table 1, rats with subtotal nephrectomies had
significantly higher serum creatinine levels compared to those
of rats with sham nephrectomies. Plasma concentrations of
calcium and phosphorus were not different between the two
groups of animals; however, plasma calcitriol levels were
significantly lower in rats with subtotal nephrectomies.
Figure 1 presents the nuclear uptake of the labeled VDR of
rats with subtotal nephrectomies and sham nephrectomies.
Nuclear uptake of the labeled VDR from rats with renal failure
was significantly lower than that from control rats throughout
each incubation period (P < 0.001).
Effect of uremic ultrafiltrate on nuclear uptake of the labeled
normal VDR
Uremic ultrafiltrate directly inhibited nuclear uptake of the
labeled VDR (Fig. 2). Nuclear uptake of the labeled VDR was
already decreased significantly 15 minutes after incubation with
uremic ultraffitrate. The decreased nuclear uptake of the labeled
VDR is not due to decreased binding of 3H-calcitriol by the
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VDR, because uremic ultrafiltrate (50% concentration) did not
affect the binding of 3H-calcitriol by the VDR (see Methods).
Nuclear uptake of the labeled VDR obtained from normal
rats infused with normal or uremic ultrafiltrate
Plasma concentrations of creatinine, calcium and phosphorus
were not different between rats infused with normal and uremic
ultrafiltrate (data not shown). However, plasma calcitriol level
was significantly lower in rats infused with uremic ultrafiltrate
(60.2 1.0 pglml, N = 4 vs. control 93.3 2.2 pg/mi, N = 4,
P < 0.001). This finding was similar to our previous reports [11,
16, 17].
As shown in Figure 3, nuclear uptake of the labeled VDR
from rats infused with uremic ultrafiltrate incubated at 2°C for
four hours and at 37°C for one hour, was significantly lower,
respectively, than that from rats infused with normal ultrafil-
trate. This study suggests that uremic factors are responsible
for the decreased nuclear uptake of the labeled VDR in renal
failure.
Discussion
The genomic action of calcitriol appears to be mediated
through a hormone-receptor complex interacting with DNA to
regulate gene expression in a manner analogous to other steroid
hormones [1]. The hormone-receptor complex is thought to
interact with their cognate DNA response elements regulating
the transcription rate of target genes and thus inducing synthe-
sis of mRNA species. These mRNAs are then translated into
bioactive proteins, which after being processed, are ultimately
responsible for the biological activity of calcitriol [2, 18]. The
biological response to calcitriol appears to be decreased in renal
failure. Recent studies suggest that decreased calcitriol produc-
tion [19] reduced hormone-receptor interaction with nuclear
chromatin [7, 81, and lower VDR concentrations [8] in renal
failure play an important role in the development of diminished
biological action of calcitriol.
We have previously demonstrated that uremic ultrafiltrate
inhibits the VDR interaction with DNA-cellulose [7, 8]. Al-
though the binding of VDR to DNA-cellulose may not directly
measure the interaction of VDR with biologically relevant DNA
sequences, as the DNA response elements possibly constitute
only a minor fraction of all DNA coupled to the cellulose, a
substantial number of experiments demonstrates that the bind-
ing characteristics of VDR to DNA-cellulose accurately predict
the behavior of VDR on its specific response elements [20—23]
and on the function of VDR [24-27]. For example, it has been
shown that the decreased VDR binding affinity for DNA-
cellulose in type II vitamin D-dependent rickets is associated
with an abnormal structure of the VDR and an end-organ
resistance to calcitriol [25, 27].
In the present study, we have extended our observation and
demonstrated that nuclear uptake of the VDR isolated from
renal failure rats was lower than that of the controls. Infusion of
uremic ultrafiltrate to normal rats also resulted in decreased
nuclear uptake of the VDR obtained from these animals,
suggesting that uremic toxins are responsible for the decreased
nuclear uptake of the VDR in renal failure. Furthermore, we
have shown that uremic factors directly inhibited nuclear up-
take of the VDR (Fig. 2). The reason for the decreased nuclear
uptake is not entirely clear; however, uremic toxins could cause
chemical modification of the DNA binding domain of the VDR.
The toxins, like pyridoxal 5-phosphate [5, 6], could also react
with the e-amino group of lysine residues in the DNA binding
domain by forming a Schiff base. The chemical modification
could inhibit the binding of the VDR to nuclear chromatin. The
chemical modification of the DNA binding domain appears to
be irreversible since the decreased nuclear uptake of the labeled
VDR not only happened in the presence of uremic toxins, but
also persisted in rats with renal failure and in rats infused with
uremic ultrafiltrate, even though the latter studies of nuclear
uptake were carried out in the absence of uremic toxins. While
the magnitude of the effect observed in this nuclear uptake
paradigm is quite modest, it is possible that diminished nuclear
uptake of the VDR complexes in the intact cells accounts for
part of the calcitriol resistance seen in renal failure.
Recent studies have indicated that interaction of the VDR
with specific vitamin D response elements require mammalian
cell nuclear factors [20, 211. These accessory factors (retinoid X
receptors (RXRs) also are members of the steroid and thyroid
hormone receptor superfamily [28, 29]. The formation of a
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Fig. 3. Intestinal nuclear uptake of the
calcitriol receptor complex of rats infused
with normal (N = 7) or uremic (N = 7)
ultrafiltrate. Nuclear uptake of the VDR from
rats infused with uremic ultrafiltrate wasUremic UF significantly lower than the VDR from rats
infused with normal ultrafiltrate (by Student's
Incubated at 37°C for 1 hour t-test).
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heterodimer made of receptor with a nuclear accessory factor is
essential for high affinity DNA binding (such as, osteopontin
response element [20, 30]). On the other hand, formation of a
homodimer of VDR is also capable of binding certain vitamin D
response elements (such as, osteocalcin response element)
without RXRs [30], suggesting that binding to certain cognate
response elements may not require the accessory factors. Our
nuclear preparation perhaps contains adequate accessory fac-
tors. Although decreased synthesis of RXR in renal failure may
account for the decreased nuclear uptake of the VDR, our in
vitro studies showed that uremic toxins inhibited nuclear uptake
of the VDR despite the presence of nuclear accessory factors
(Fig. 2).
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